Zinc: uses, evidence, dosing and safety

Zinc has more good evidence behind it than almost any supplement on the shelf, and almost none of it supports the product people actually buy.

Three uses hold up: a lozenge for an adult’s cold, a high-dose formula for eye disease that has already started, and treatment for children in places where zinc deficiency is common. What sells is a low-dose daily capsule taken indefinitely as immune insurance, which is none of those.

The thread running through all three is worth having up front. Zinc works when it corrects a shortfall or acts directly on the tissue in question. It does not work as a general tonic, and past a certain point more of it stops adding anything and starts costing something.

What zinc is

Zinc is a trace mineral, which means the body needs a small and non-negotiable amount of it. Zinc is found in cells throughout the body. It is needed for the body’s defensive (immune) system to properly work.

Its other jobs are wide-ranging. It plays a role in cell division, cell growth, wound healing, and the breakdown of carbohydrates, and zinc is also needed for the senses of smell and taste, which is why deficiency can blunt both.

Most people get enough from food. Animal proteins are a good source of zinc, with beef, pork, and lamb containing more zinc than fish. Other good sources of zinc are nuts, whole grains, legumes, and yeast.

Who actually runs short

This is the question that decides whether any of the rest applies to you, and it is the one supplement marketing works hardest to blur.

One dietary asymmetry does most of the work. Fruits and vegetables are not good sources, because the zinc in plant foods is not as available for use by the body as the zinc from animal sources. Someone eating meat several times a week is unlikely to be short. A person eating almost none, especially alongside a diet heavy in whole grains and legumes, plausibly is.

Deficiency is not subtle when it arrives. Symptoms of zinc deficiency include frequent infections, loss of hair, poor appetite, slow growth, and wounds that take a long time to heal.

Population matters as much as diet. The childhood trials discussed below were mostly run in Asian countries that were at high risk of zinc deficiency, and their results do not transfer to a well-fed household in a high-income country. That is not a technicality. It is the difference between a treatment and a placebo.

How zinc is thought to shorten a cold

The proposed mechanism is local rather than systemic, and it explains the delivery format.

A lozenge dissolves in the mouth and throat, releasing zinc ions where cold viruses are replicating. That is why the trials that work use lozenges rather than swallowed capsules, and why formulation details keep appearing in the literature: Cochrane’s own framing notes that inadequate treatment masking and reduced bioavailability of zinc from some formulations have been cited as influencing results.

In other words, a zinc capsule swallowed whole is not the intervention that was tested. Cochrane says so directly, restricting its advice to when using zinc lozenges (not as syrup or tablets).

What the evidence says about zinc and colds

The headline result

A meta-analysis included 17 trials involving a total of 2121 participants. Compared with patients given placebo, those receiving zinc had a shorter duration of cold symptoms, by 1.65 days.

Losing a day and a half from a cold is a real benefit for something available over the counter. Timing is part of the deal: zinc administered within 24 hours of onset of symptoms reduces the duration of common cold symptoms in healthy people, and the trials that started later are not the ones driving the result.

The two things that complicate it

First, the trials disagree violently. Heterogeneity was high, at 95%, and it stayed high across every subgroup, including by age, dose of ionized zinc and zinc formulation. A figure of 95% means almost all the variation between trial results comes from genuine differences between the trials rather than chance. The average is real; it is also an average of studies that do not agree. Cochrane reaches the same place: the very high heterogeneity means that the averaged estimates must be viewed with caution.

Second, the effect is not universal. Zinc shortened the duration of cold symptoms in adults by 2.63 days, but no significant effect was seen among children, where the estimate was 0.26 days with a range that crosses zero.

That split is routinely lost in coverage, and it is the single most practical finding on the page.

The lozenge-specific picture

Restricting to lozenge trials at higher doses sharpens things. Across seven randomized trials with 575 participants, the mean common cold duration was 33% shorter for the zinc groups.

The same analysis settles two marketing questions. Three trials that used lozenges composed of zinc acetate found that colds were shortened by 40% and four trials that used zinc gluconate by 28%, but the difference between the two salts was not significant.

And on dose: five trials used zinc doses of 80-92 mg/day, common cold duration was reduced by 33%, and two trials used zinc doses of 192-207 mg/day and found an effect of 35%. The conclusion drawn is blunt. There is no evidence that zinc doses over 100 mg/day might lead to greater efficacy in the treatment of the common cold.

One reassurance sits alongside that. Pooling the individual patients from three acetate trials, the effect of zinc lozenges was not modified by allergy status, smoking, baseline severity of the common cold, age, gender or ethnic group, so within the adult range the overall estimates for effect seemed applicable over a wide range of common cold patients.

What the evidence says about zinc and macular degeneration

This is the strongest long-term evidence zinc has, and it is missing from most discussion of the mineral entirely.

Age-related macular degeneration, or AMD, is the leading cause of central vision loss in older adults. The Age-Related Eye Disease Study, known as AREDS, set out to test whether supplements could slow it, running as an 11-center double-masked clinical trial in 3,640 people aged 55 to 80, followed for an average of 6.3 years.

The design matters, because one arm was zinc on its own. Participants were randomly assigned to antioxidants, to zinc, 80 mg, as zinc oxide and copper, 2 mg, as cupric oxide, to both together, or to placebo.

What it found

Taking the supplements reduces the risk of progression from intermediate to advanced AMD by about 25 percent, and the same summary puts the reduction in central vision loss at 19% in that group.

Zinc carried a large share of that on its own. Among the participants who actually stood to gain, both zinc and antioxidants plus zinc significantly reduced the odds of developing advanced AMD in this higher-risk group.

The pooled picture agrees. A 2023 Cochrane review found five studies compared zinc with placebo and reported a lower progression to late AMD over six years, with moderate-certainty evidence behind it.

The three caveats that decide whether it applies to you

The first is the one people get wrong. These supplements do not prevent AMD onset. They slow a disease that has already started, and the follow-on trial made that explicit by design: AREDS2 excluded people without AMD or with early AMD because AREDS data showed no benefit for these individuals. Cochrane puts the same point in terms of who gains most, noting that people with intermediate AMD have a higher chance of benefiting from antioxidant supplements because their risk of progression is higher than people with early AMD.

The second is dose, and it repeats the cold finding. AREDS2 tested lowering the zinc dose to 25 mg, and the investigators found no significant changes in the effectiveness of the formulation when they removed beta-carotene or reduced the zinc dose. A quarter of the zinc did the same job.

The third is copper, and it is the most useful detail on this page. The 2 mg of copper in the formula was added to avoid zinc-related copper deficiency. The people who ran the only large long-term zinc trial knew that sustained high-dose zinc pushes copper down, and they engineered around it from the start. Anyone taking daily zinc without copper is running the protocol with the safety component removed.

What the evidence says about zinc and diarrhea in children

Here zinc works in children, which is the mirror image of the cold result, and the reason is the thread of this whole page.

A Cochrane review found thirty-three trials that included 10,841 children met our inclusion criteria, and zinc during acute illness is currently recommended by the World Health Organization.

In children older than six months, zinc may shorten the average duration by around half a day and probably reduces the number of children whose symptoms persist until day seven. Where children were undernourished the benefit roughly doubled: in children with signs of malnutrition the effect appears greater, cutting around a day, on high-certainty evidence.

And then the limit. In children younger than six months of age, the available evidence suggests zinc supplementation may have no effect on the mean duration. The authors’ own conclusion draws the boundary as sharply as anyone could want: the current evidence does not support the use of zinc supplementation in children less six months of age, in well-nourished children, and in settings where children are at low risk of zinc deficiency.

Read that alongside the cold trials and the pattern is hard to miss. Zinc helps when zinc is what was missing.

It is not free, either. Zinc supplementation increased the risk of vomiting in both age groups.

Myths about zinc, and what the evidence says

“Take it daily to keep your immune system strong.” The strong evidence covers treatment during a cold. Prevention is a thinner file, and Cochrane did look at it: two preventive trials found a lower rate of developing a cold, but the review still concluded that regarding prophylactic zinc supplementation, currently no firm recommendation can be made because of insufficient data. Daily use is also where the copper problem lives.

“More zinc, faster recovery.” Doubling the cold dose from around 90 mg to around 200 mg changed the effect by two percentage points. Quartering the eye-formula dose changed nothing measurable. Two separate literatures, same answer.

“Zinc acetate is the superior form.” The difference between salts was not significant, and properly composed zinc gluconate lozenges may be as effective as zinc acetate lozenges.

“It works for the whole family.” Not for colds, where it failed in children. For childhood illness in a well-nourished household, the Cochrane authors specifically exclude that group too.

“A nasal gel gets it closer to the virus.” This is the one form with a documented harm, described below.

“It is a mineral, so side effects are not a concern.” Adverse events were significantly more common than placebo in the cold trials, and vomiting was more common in the childhood trials.

Dosing and forms of zinc

Four different numbers get confused with each other, so they are worth separating.

For dietary sufficiency the requirement is small: 11 mg a day for males aged 14 and over, and 8 mg a day for females aged 19 and over, rising slightly in pregnancy and lactation.

For treating a cold the trial doses were an order of magnitude higher, at 80 to 207 mg a day, as lozenges, started within a day of symptoms and taken only during the illness. Cochrane pins its practical advice to a dose of at least 75 mg a day: for those considering using zinc it would be best to use it at this dose throughout the cold.

For macular degeneration the dose is 80 mg daily and genuinely long-term, but only as part of the tested formula, only with copper, and only for people who already have intermediate disease. The lower 25 mg version performed just as well.

For everyone else the honest number is zero, on top of a diet with some animal protein in it.

Forms sold include gluconate, acetate, picolinate, citrate and carnosine. The trial evidence covers acetate and gluconate lozenges and found no clear winner. The optimal lozenge composition and dosage scheme need to be investigated further, so anyone shopping on form is ahead of the data.

Safety, side effects and who should be careful

Short-term side effects are common. The occurrence of any adverse event, bad taste and nausea were all more frequent in the zinc groups than in placebo groups, with bad taste and nausea both running about 1.6 times as likely.

That matters more than usual here. The meta-analysts make the point directly: a good safety and tolerance profile is essential when treating this generally mild illness. A remedy that makes you queasy to save a day of sniffles is a genuine trade rather than a free win.

At higher intakes, zinc supplements taken in large amounts may cause diarrhea, abdominal cramps, and vomiting. Across the eye trials, gastrointestinal symptoms were the main reported adverse effect. One further signal appeared there: zinc was associated with a higher risk of genitourinary problems in men, though no difference was seen between high- and low-dose zinc groups in AREDS2.

The nasal products are a separate question

Zinc gels and sprays applied inside the nose are not a variant of the lozenge, and the evidence does not carry across.

Commercial preparations of intranasal zinc gluconate gel are marketed as a remedy for the common cold, and intranasal zinc has been reported as a cause of anosmia in humans and animals. A retrospective case series described seventeen patients presenting with anosmia after the use of intranasal zinc gluconate, with a consistent story: all patients reported sniffing deeply when applying the gel, this was followed by an immediate sensation of burning lasting minutes to hours, and loss of sense of smell was then perceived within 48 hours. Seven of 17 patients never developed symptoms of an upper respiratory infection, so a cold cannot explain their loss of smell.

A case series cannot tell you how often this happens, and that limit is real. It can tell you the failure mode exists and what it looks like, which is enough to make the nasal route the wrong way to take a mineral that has a perfectly good oral one.

The long-term concern

A long-term excess intake of zinc can lead to copper, iron, or magnesium deficiency. Zinc and copper compete for absorption, so sustained high zinc quietly pushes copper down, and copper deficiency produces anemia and neurological symptoms that are rarely traced back to a supplement bottle.

This is the argument against open-ended daily zinc for people who are not deficient, and it is the part the immune-support marketing never mentions. The eye trials show the fix is not complicated. They just show that somebody has to actually do it.

Interactions

The clinically important interaction is with copper, described above, and it is a nutrient interaction rather than a drug one.

Beyond that, zinc binds several classes of medication in the gut and can reduce their absorption, which is why separating doses by a couple of hours is standard pharmacy advice. Anyone on regular medication should check timing with a pharmacist rather than assume a mineral is inert.

Bottom line on zinc

If you are an adult and you start a high-dose lozenge within a day of a cold beginning, the evidence says you will probably be better around a third sooner, at the cost of a bad taste and possible nausea. That is legitimate and it is narrow.

If you have been told you have intermediate macular degeneration, the eye formula is one of the better-evidenced things available to you, and the zinc in it is doing real work. If you have healthy eyes, it does nothing for you at all.

If you are giving zinc to a child for a cold, the pooled trials do not support it. For childhood illness in a well-nourished household, the trial authors exclude that setting explicitly.

And if you are taking a daily zinc capsule as general immune insurance while eating animal protein, you are outside all three evidence bases and slowly running your copper down. Zinc rewards being used for something specific. It punishes being taken just in case.